Michael R Zalutsky

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Top Venues

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

International journal of nanomedicine

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Honoka Obata, Mikako Ogawa, Michael R Zalutsky
DNA Repair Inhibitors: Potential Targets and Partners for Targeted Radionuclide Therapy. Pharmaceutics 15 (7) (2023)
Yutian Feng, Rebecca Meshaw, Xiao-Guang Zhao, Stephen A Jannetti, Ganesan Vaidyanathan, Michael R Zalutsky
Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose 211 At-Labeled Anti-HER2 Single Domain Antibody Fragment. Journal of nuclear medicine : official publication, Society of Nuclear Medicine (2022)
Yutian Feng, Samantha M Sarrett, Rebecca L Meshaw, Ganesan Vaidyanathan, Mike A Cornejo, Brian M Zeglis, Michael R Zalutsky
Site-Specific Radiohalogenation of a HER2-Targeted Single-Domain Antibody Fragment Using a Novel Residualizing Prosthetic Agent. Journal of medicinal chemistry 65 (22) (2022)
Yang Liu, Zhengyuan Zhou, Yutian Feng, Xiao-Guang Zhao, Ganesan Vaidyanathan, Michael R Zalutsky, Tuan Vo-Dinh
Gold Nanostars: A Novel Platform for Developing 211At-Labeled Agents for Targeted Alpha-Particle Therapy. International journal of nanomedicine 16 (2021)